Hovione, having over 50 years’ experience in active pharmaceutical ingredient and drug product intermediate development and compliant manufacture, announced the appointment of Dr Justin Hughey to lead the particle design sciences at its site in New Jersey. With over 30 publications, posters and book chapters Hughey is an acknowledged expert in the field of solubilisation including the creation of amorphous solid dispersions with emphasis on hot melt extrusion. Hughey most recently served as the Director of Research for Austin-based Enavail.
“I am delighted to announce the appointment of Hughey. With his experience and deep scientific knowledge in developing traditional and non-traditional dosage forms with a strong emphasis on hot melt extrusion and other novel processing techniques, I believe he will help speedily solve bioavailability challenges brought to us by our customers,” said Dr Colin Minchom, Vice President Particle Design.
“I am excited about the opportunity to lead the scientific efforts of the particle design team at Hovione New Jersey. I have always admired Hovione’s capabilities in the area of spray drying and was pleased to hear that they were adding hot melt extrusion to their portfolio. I am looking forward to making significant contributions to this area and offering customers a range of solubility enhancement options, thus improving the probability of success for their molecule,” said Hughey.
Hughey earned his Ph.D. in pharmaceutics from The University of Texas at Austin. His pharmaceutical development experience extends to particle engineering technologies for pulmonary delivery as well as controlled and immediate release solid oral dosage forms.
EP News Bureau – Mumbai
- Advertisement -
